EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sirt6 protects retinal ganglion cells and optic nerve from degeneration during aging and glaucoma

Fan Xia, Shuizhen Shi, Erick Palacios, Wei Liu, Seth E Buscho, Joseph Li, Shixia Huang, Gianmarco Vizzeri, Xiaocheng Charlie Dong, Massoud Motamedi, Wenbo Zhang, Hua Liu

Molecular Therapy · 2024

DOI: 10.1016/j.ymthe.2024.04.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2024. Verfasst von Fan Xia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA. Hauptthemen laut MEDLINE: Retinal Ganglion Cells, Sirtuins, Glaucoma, Optic Nerve. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NEI NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glaucoma is characterized by the progressive degeneration of retinal ganglion cells (RGCs) and their axons, and its risk increases with aging. Yet comprehensive insights into the complex mechanisms are largely unknown. Here, we found that anti-aging molecule Sirt6 was highly expressed in RGCs. Deleting Sirt6 globally or specifically in RGCs led to progressive RGC loss and optic nerve degeneration during aging, despite normal intraocular pressure (IOP), resembling a phenotype of normal-tension glaucoma. These detrimental effects were potentially mediated by accelerated RGC senescence through Caveolin-1 upregulation and by the induction of mitochondrial dysfunction. In mouse models of high-tension glaucoma, Sirt6 level was decreased after IOP elevation. Genetic overexpression of Sirt6 globally or specifically in RGCs significantly attenuated high tension-induced degeneration of RGCs and their axons, whereas partial or RGC-specific Sirt6 deletion accelerated RGC loss. Importantly, therapeutically targeting Sirt6 with pharmacological activator or AAV2-mediated gene delivery ameliorated high IOP-induced RGC degeneration. Together, our studies reveal a critical role of Sirt6 in preventing RGC and optic nerve degeneration during aging and glaucoma, setting the stage for further exploration of Sirt6 activation as a potential therapy for glaucoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal Ganglion CellsSirtuinsGlaucomaOptic NerveAgingDisease Models, AnimalAnimalsMiceIntraocular PressureHumansAxonsMice, KnockoutNerve Degeneration

Stichwörter der Autor:innen

AAV2Sirt6Sirt6 activatoragingglaucomaneurodegenerationoptic nerveretinal ganglion cells

Substanzen

SirtuinsSirt6 protein, mouse

Autor:innen und Institutionen

  • Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA.
  • Advanced Technology Cores, Department of Molecular and Cellular Biology, Department of Education, Innovation and Technology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Neurobiology, University of Texas Medical Branch, Galveston, TX 77555, USA. Electronic address…
  • Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA. Electronic address: hualiu@utmb.edu.

Förderung

  • NIDDK NIH HHS
  • NEI NIH HHS
  • NIA NIH HHS
  • University of Texas System
  • Retina Research Foundation
  • Cancer Prevention and Research Institute of Texas
  • National Institutes of Health
  • NEI

Zitieren

APA

Xia, F., Shi, S., Palacios, E., Liu, W., Buscho, S. E., Li, J., Huang, S., Vizzeri, G., Dong, X. C., Motamedi, M., Zhang, W., & Liu, H. (2024). Sirt6 protects retinal ganglion cells and optic nerve from degeneration during aging and glaucoma. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2024.04.030

Vancouver

Xia F, Shi S, Palacios E, Liu W, Buscho SE, Li J, et al. Sirt6 protects retinal ganglion cells and optic nerve from degeneration during aging and glaucoma. Molecular Therapy. 2024. doi:10.1016/j.ymthe.2024.04.030

BibTeX
@article{Xia2024,
  author = {Xia, Fan and Shi, Shuizhen and Palacios, Erick and Liu, Wei and Buscho, Seth E and Li, Joseph and Huang, Shixia and Vizzeri, Gianmarco and Dong, Xiaocheng Charlie and Motamedi, Massoud and Zhang, Wenbo and Liu, Hua},
  title = {Sirt6 protects retinal ganglion cells and optic nerve from degeneration during aging and glaucoma},
  journal = {Molecular Therapy},
  year = {2024},
  doi = {10.1016/j.ymthe.2024.04.030}
}
Kostenlos starten →